Informatie:
Fout:
ID
14780
Beschrijving
A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-01); ODM derived from: https://clinicaltrials.gov/show/NCT00520637
Link
https://clinicaltrials.gov/show/NCT00520637
Trefwoorden
Versies (1)
- 27-04-16 27-04-16 -
Geüploaded op
27 april 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Advanced Solid Tumors NCT00520637
Eligibility Advanced Solid Tumors NCT00520637
- StudyEvent: Eligibility
Similar models
Eligibility Advanced Solid Tumors NCT00520637
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
solid tumor or lymphoma
Item
histologically or cytologically confirmed diagnosis of advanced and/or metastatic solid tumor or lymphoma that is refractory to standard therapy
boolean
C0280100 (UMLS CUI [1])
C0024299 (UMLS CUI [2])
C0024299 (UMLS CUI [2])
measurable or evaluable disease
Item
measurable or evaluable disease
boolean
C1513041 (UMLS CUI [1])
ecog
Item
score of 0 to 2 on the ecog performance scale
boolean
C1520224 (UMLS CUI [1])
medical illness
Item
concurrent serious medical illness
boolean
C0262926 (UMLS CUI [1])
central nervous system (cns) tumor involvement
Item
known, clinically suspected, or history of central nervous system (cns) tumor involvement
boolean
C0085136 (UMLS CUI [1])
active diarrhea
Item
active diarrhea
boolean
C0011991 (UMLS CUI [1])
coagulation disorder
Item
known history of coagulation disorder
boolean
C0005779 (UMLS CUI [1])
cytochrome p450 3a4
Item
patients requiring cytochrome p450 3a4 (cyp3a4) enzyme inducing medications
boolean
C3830625 (UMLS CUI [1])
ketoconazole
Item
requirement for ketoconazole or other strong inhibitor of cyp3a4 enzymes
boolean
C0022625 (UMLS CUI [1])
chemotherapy, immunotherapy
Item
prior chemotherapy, immunotherapy, investigational agent, or other therapy used to treat the cancer within 4 weeks (6 weeks for prior treatment with mitomycin c or nitrosoureas) prior to the scheduled administration of ezn-2208
boolean
C0392920 (UMLS CUI [1])
C0021083 (UMLS CUI [2])
C0021083 (UMLS CUI [2])